Doxycycline hyclate 50 MG Oral Tablet — RxCUI 1652674
RxNorm drug concept · Semantic clinical drug
RxCUI 1652674
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
51 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1652674
Official nameDoxycycline hyclate 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped18
Package NDCs mapped51
Reported Medicaid activity (SDUD)22,997 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxycycline Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The IV form is used when you're not able to swallow or absorb oral medication — for example, if you're too sick, vomiting, or need a faster, more reliable delivery of the antibioti...
- Why am I getting doxycycline through an IV instead of just taking a pill?
- It depends on what infection you're being treated for. For most infections, treatment continues for at least 24 to 48 hours after your fever and symptoms have cleared. For somethin...
- How long will I need to be on this antibiotic?
🕸️ Concept Web — How Doxycycline hyclate 50 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Doxycycline hyclate 50 MG Oral Tablet
RxCUI 1652674 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Doxycycline
3640IN -
Doxycycline hyclate
23663PIN
-
Doxycycline
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Targadox
1806943BN
-
Targadox
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxycycline Oral Tablet
371966SCDF -
Doxycycline hyclate Oral Tablet
2648109SCDFP -
Doxycycline Oral Product
1160778SCDG -
Doxycycline Pill
1160779SCDG -
Doxycycline hyclate Oral Product
2663263SCDGP -
Doxycycline hyclate Pill
2661949SCDGP -
Doxycycline Oral Tablet [Targadox]
1806945SBDF -
Doxycycline hyclate Oral Tablet [Targadox]
2656000SBDFP - +5 more in this family
-
Doxycycline Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxycycline hyclate 50 MG
1649404SCDC -
Doxycycline hyclate 50 MG Oral Tablet [Targadox]
1806948SBD -
Doxycycline hyclate 50 MG [Targadox]
1806944SBDC
-
Doxycycline hyclate 50 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxycycline hyclate 50 MG
SCDC · 1649404 -
Doxycycline Oral Tablet
SCDF · 371966 -
Doxycycline hyclate Oral Tablet
SCDFP · 2648109 -
Doxycycline Oral Product
SCDG · 1160778 -
Doxycycline Pill
SCDG · 1160779 -
Doxycycline hyclate Oral Product
SCDGP · 2663263 -
Doxycycline hyclate Pill
SCDGP · 2661949
Brand-Name Concepts
-
Doxycycline hyclate 50 MG Oral Tablet [Targadox]
SBD · 1806948 -
Doxycycline hyclate 50 MG [Targadox]
SBDC · 1806944 -
Doxycycline Oral Tablet [Targadox]
SBDF · 1806945 -
Doxycycline hyclate Oral Tablet [Targadox]
SBDFP · 2656000 -
Targadox Oral Product
SBDG · 1806946 -
Targadox Pill
SBDG · 1806947 -
Targadox
BN · 1806943
📦 FDA Products & Package NDCs
18 products · 51 package NDCs
51 package NDCs map to RxCUI 1652674 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 46708-0353-20 | 20 TABLET, FILM COATED in 1 BOTTLE (46708-353-20) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2020-05-15 |
| 46708-0353-50 | 50 TABLET, FILM COATED in 1 BOTTLE (46708-353-50) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2020-05-15 |
| 46708-0353-71 | 500 TABLET, FILM COATED in 1 BOTTLE (46708-353-71) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2020-05-15 |
| 46708-0499-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-499-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2021-09-15 |
| 62135-0417-46 | 60 mL in 1 BOTTLE, GLASS (62135-417-46) | doxycycline | Chartwell RX LLC | 2018-01-01 |
| 62135-0625-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-625-60) | Doxycycline Hyclate | Chartwell RX LLC | 2021-07-27 |
| 62135-0626-01 | 100 TABLET, FILM COATED in 1 BOTTLE (62135-626-01) | Doxycycline Hyclate | Chartwell RX LLC | 2020-09-01 |
| 62135-0626-05 | 500 TABLET, FILM COATED in 1 BOTTLE (62135-626-05) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0626-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (62135-626-10) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-12 | 120 TABLET, FILM COATED in 1 BOTTLE (62135-626-12) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-20 | 20 TABLET, FILM COATED in 1 BOTTLE (62135-626-20) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0626-23 | 210 TABLET, FILM COATED in 1 BOTTLE (62135-626-23) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-28 | 28 TABLET, FILM COATED in 1 BOTTLE (62135-626-28) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-31 | 300 TABLET, FILM COATED in 1 BOTTLE (62135-626-31) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-40 | 400 TABLET, FILM COATED in 1 BOTTLE (62135-626-40) | Doxycycline Hyclate | Chartwell RX LLC | 2020-01-01 |
| 62135-0626-50 | 50 TABLET, FILM COATED in 1 BOTTLE (62135-626-50) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0626-96 | 2000 TABLET, FILM COATED in 1 BOTTLE (62135-626-96) | Doxycycline Hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0877-46 | 60 mL in 1 BOTTLE, GLASS (62135-877-46) | doxycycline | Chartwell RX LLC | 2024-03-27 |
| 62135-0984-05 | 500 CAPSULE in 1 BOTTLE (62135-984-05) | doxycycline hyclate | Chartwell RX LLC | 2022-02-17 |
| 62135-0984-50 | 50 CAPSULE in 1 BOTTLE (62135-984-50) | doxycycline hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0985-01 | 100 CAPSULE in 1 BOTTLE (62135-985-01) | doxycycline hyclate | Chartwell RX LLC | 2020-09-01 |
| 62135-0985-05 | 500 CAPSULE in 1 BOTTLE (62135-985-05) | doxycycline hyclate | Chartwell RX LLC | 1984-09-11 |
| 62135-0985-10 | 1000 CAPSULE in 1 BOTTLE (62135-985-10) | doxycycline hyclate | Chartwell RX LLC | 2020-09-01 |
| 62135-0985-50 | 50 CAPSULE in 1 BOTTLE (62135-985-50) | doxycycline hyclate | Chartwell RX LLC | 1984-09-11 |
| 62332-0353-20 | 20 TABLET, FILM COATED in 1 BOTTLE (62332-353-20) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2020-05-15 |
| 62332-0353-50 | 50 TABLET, FILM COATED in 1 BOTTLE (62332-353-50) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2020-05-15 |
| 62332-0353-71 | 500 TABLET, FILM COATED in 1 BOTTLE (62332-353-71) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2020-05-15 |
| 62332-0499-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-499-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2021-09-15 |
| 64380-0225-01 | 60 TABLET in 1 BOTTLE (64380-225-01) | DOXYCYCLINE HYCLATE | Strides Pharma Science Limited | 2026-05-14 |
| 68999-0417-46 | 60 mL in 1 BOTTLE, GLASS (68999-417-46) | doxycycline | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0625-60 | 60 TABLET, FILM COATED in 1 BOTTLE (68999-625-60) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-02 | 20 TABLET, FILM COATED in 1 BOTTLE (68999-626-02) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2022-06-24 |
| 68999-0626-05 | 500 TABLET, FILM COATED in 1 BOTTLE (68999-626-05) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0626-06 | 100 TABLET, FILM COATED in 1 BOTTLE (68999-626-06) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2022-06-24 |
| 68999-0626-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (68999-626-10) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-12 | 120 TABLET, FILM COATED in 1 BOTTLE (68999-626-12) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0626-23 | 210 TABLET, FILM COATED in 1 BOTTLE (68999-626-23) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-28 | 28 TABLET, FILM COATED in 1 BOTTLE (68999-626-28) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-30 | 30 TABLET, FILM COATED in 1 BOTTLE (68999-626-30) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-11-12 |
| 68999-0626-31 | 300 TABLET, FILM COATED in 1 BOTTLE (68999-626-31) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-40 | 400 TABLET, FILM COATED in 1 BOTTLE (68999-626-40) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-50 | 50 TABLET, FILM COATED in 1 BOTTLE (68999-626-50) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0626-96 | 2000 TABLET, FILM COATED in 1 BOTTLE (68999-626-96) | Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0984-50 | 50 CAPSULE in 1 BOTTLE (68999-984-50) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0985-01 | 100 CAPSULE in 1 BOTTLE (68999-985-01) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2025-09-17 |
| 68999-0985-05 | 500 CAPSULE in 1 BOTTLE (68999-985-05) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0985-10 | 1000 CAPSULE in 1 BOTTLE (68999-985-10) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 68999-0985-50 | 50 CAPSULE in 1 BOTTLE (68999-985-50) | doxycycline hyclate | Chartwell Governmental & Specialty RX, LLC | 2021-09-01 |
| 69489-0111-05 | 5 TABLET in 1 BOTTLE (69489-111-05) | TARGADOX | Journey Medical Corporation | 2016-08-29 |
| 69489-0111-60 | 60 TABLET in 1 BOTTLE (69489-111-60) | TARGADOX | Journey Medical Corporation | 2016-08-29 |
Observed labelers:
Chartwell RX LLC (20) ·
Chartwell Governmental & Specialty RX, LLC (19) ·
Alembic Pharmaceuticals Inc. (4) ·
Alembic Pharmaceuticals Limited (4) ·
Journey Medical Corporation (2) ·
JG Pharma Inc. (1)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.